Loading
EML4 (Echinoderm microtubule-associated protein-like 4) is a gene. The public catalogues list it as a drug target and a fusion partner, and an approved or late-stage drug is recorded against it. Tied to Lung cancer, Thyroid cancer and Non-small-cell lung cancer. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.
Essential for the formation and stability of microtubules (MTs). Required for the organisation of the mitotic spindle and for the proper attachment of kinetochores to MTs. Promotes the recruitment of NUDC to the mitotic spindle for mitotic progression. Location: Cytoplasm, cytoskeleton; Cytoplasm; Cytoplasm, cytoskeleton, spindle; Cytoplasm, cytoskeleton, microtubule organizing center (UniProt). Locus 2p21 (HGNC).
No product in the corpus is aimed at this target yet.
No trial in the corpus names this target or one of its products.
No recorded escape route names this target.
No pathway diagram carries this target as a node.
No companion diagnostic in the registry measures this target.
No model entry for this target yet; check the cancer entries on the models page.
No open questions recorded for this target yet. Suggest one.
Query for this target: (TITLE:"EML4" OR ABSTRACT:"EML4" OR TITLE:"EMAP like 4" OR ABSTRACT:"EMAP like 4" OR TITLE:"Echinoderm microtubule-associated protein-like 4" OR ABSTRACT:"Echinoderm microtubule-associated protein-like 4" OR TITLE:"ROPP120" OR ABSTRACT:"ROPP120" OR TITLE:"ELP120" OR ABSTRACT:"ELP120" OR TITLE:"C2orf2" OR ABSTRACT:"C2orf2") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about EML4, not a curated reading list.
The dossier as machine-readable JSON, at /api/v1/dossiers/eml4.json: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/eml4.json. Licence CC BY-NC 4.0.